Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
A vaccine designed to enhance T-cell activity could help CAR-T therapy work better against solid tumors.
Some people with blood cancers, however, may not be as well protected.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.